Enanta Pharmaceuticals shares owned by Krensavage Asset Management
Quarter-by-quarter ownership of Enanta Pharmaceuticals (ENTA) shares owned by Krensavage Asset Management
from 13F filings
Historical chart of Krensavage Asset Management investment in Enanta Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Enanta Pharmaceuticals held by Krensavage Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Enanta Pharmaceuticals by Krensavage Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $7.0M | 743k | 9.41 |
2023-09-30 | $8.2M | 735k | 11.17 |
2023-06-30 | $15M | 688k | 21.40 |
2023-03-31 | $24M | 603k | 40.44 |
2022-12-31 | $28M | 595k | 46.52 |
2022-09-30 | $31M | 589k | 51.87 |
2022-06-30 | $30M | 625k | 47.27 |
2022-03-31 | $39M | 549k | 71.18 |
2021-12-31 | $42M | 564k | 74.78 |
2021-09-30 | $53M | 937k | 56.81 |
2021-06-30 | $41M | 940k | 44.01 |
2021-03-31 | $43M | 863k | 49.32 |
2020-12-31 | $36M | 859k | 42.10 |
2020-09-30 | $38M | 825k | 45.78 |
2020-06-30 | $38M | 763k | 50.21 |
2020-03-31 | $36M | 700k | 51.43 |
2019-12-31 | $30M | 489k | 61.78 |
2019-09-30 | $30M | 499k | 60.08 |
2019-06-30 | $41M | 480k | 84.38 |
2019-03-31 | $46M | 476k | 95.52 |
2018-12-31 | $44M | 536k | 82.24 |
2018-09-30 | $44M | 511k | 85.46 |
2018-06-30 | $60M | 519k | 115.90 |
2018-03-31 | $60M | 740k | 80.91 |
2017-12-31 | $51M | 867k | 58.68 |
2017-09-30 | $47M | 1.0M | 46.80 |
2017-06-30 | $40M | 1.1M | 35.98 |
2017-03-31 | $34M | 1.1M | 30.80 |
2016-12-31 | $35M | 1.1M | 33.50 |
2016-09-30 | $27M | 1000k | 26.61 |
2016-06-30 | $20M | 907k | 22.05 |
2016-03-31 | $26M | 883k | 29.37 |
2015-12-31 | $29M | 878k | 33.02 |
2015-09-30 | $26M | 730k | 36.14 |
2015-06-30 | $32M | 707k | 44.99 |
2015-03-31 | $13M | 424k | 30.62 |
More positions owned by Krensavage Asset Management
View all positions for Krensavage Asset Management